0
CLINICAL NOTES   |    
USES AND ABUSES OF ANTIPARKINSONIAN MEDICATION
A. ST. JEAN; M. W. DONALD; T. A. BAN
Am J Psychiatry 1964;120:801-803.
View Article Information
Hôpital des Laurentides, L'Annonciation, Quebec, and The Verdun Protestant Hospital, Verdun, Quebec.
text A A A
PDF of the full text article.
Abstract
The antiparkinsonian medication of 30 mental hospital patients was suddenly removed. Half the patients were then placed on placebo. During the ensuing month they did not manifest any significant change in extrapyramidal symptomatology. The other half of the patients received no replacement and during the ensuing month their extrapyramidal symptoms became significantly worse (p≤.02) than during the pretrial period. In other words, it was not the withdrawal of the actual antiparkinsonian compound, but the withdrawal of the factor of non-specific psychological treatment which brought about an increase of parkinsonian manifestations. It should be added that one-third of those who received no replacement whatsoever showed no increase of parkinsonian manifestations.These results would imply that potentially toxic antiparkinsonian medication was unnecessary in the vast majority of patients, although two-thirds would require some sort of non-specific psychological treatment to keep their symptoms in check.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    PubMed Articles